BridgeMD
New treatment option for Quality Indicators, Health Care
Official title Artificial Intelligence in Colonoscopy
ClinicalTrials.gov ID: NCT06786793
What this study is testing
- What it's testing
- Colorectal cancer is the second most common malignancy in the countries of the European Union. Colonoscopy is the primary method for detecting and preventing the development of colorectal cancer is endoscopic examination.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 65
You may be able to join if
- Consent to participate in the study,
- Age between 50 and 65 years,
- Scheduled outpatient colonoscopy.
You likely can't join if
- Previous colonoscopy,
- History of colorectal surgery,
- Ongoing biological therapy for any indication,
- Primary sclerosing cholangitis,
- Familial polyposis syndrome,
- Chronic diarrhea,
See the full eligibility criteria
- Consent to participate in the study,
- Age between 50 and 65 years,
- Scheduled outpatient colonoscopy.
- Previous colonoscopy,
- History of colorectal surgery,
- Ongoing biological therapy for any indication,
- Primary sclerosing cholangitis,
- Familial polyposis syndrome,
- Chronic diarrhea,
- Ulcerative colitis,
- Crohn's disease.
The study team makes the final eligibility decision.
Where it's taking place
- Krakow, Lesser Poladn, Poland
- Krakow, Lesser Polasd, Poland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Krakow, Lesser Poladn, Poland; Krakow, Lesser Polasd, Poland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.